Evolent Health, INC Schedule 13G passive stakes

The Vanguard Group filed an amended Schedule 13G, reporting zero beneficial ownership in Evolent Health Inc. following an internal reporting realignment.

Eventide Asset Management, Finny Kuruvilla, and Robin C. John have filed an amended Schedule 13G, disclosing a 0.0% beneficial ownership in Evolent Health, Inc. Class A Common Stock as of December 31, 2025.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, reported beneficial ownership of 8.1% of Evolent Health, Inc.'s Class A Common Stock as of December 31, 2025.

FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a beneficial ownership of 0.7% of Evolent Health Inc.'s Class A Common Stock as of December 31, 2025.

The Vanguard Group reported a 7.98% beneficial ownership stake in Evolent Health Inc., holding 8,914,065 common shares as of December 31, 2025.

Rubicon Fund II LP and affiliated entities, including Adam Boehler, have disclosed a 5.21% beneficial ownership stake in Evolent Health, Inc.'s Class A Common Stock.

Durable Capital Partners LP has reported a 0.0% beneficial ownership in Evolent Health, Inc.'s Class A Common Stock, indicating a full divestment or reduction below reporting thresholds.

Eventide Asset Management, along with Finny Kuruvilla and Robin C. John, reported a 5.4% beneficial ownership stake in Evolent Health, Inc., totaling 6,292,511 Class A Common Stock shares as of September 30, 2025.

FMR LLC and its affiliates, including Abigail P. Johnson, reported an 8.0% beneficial ownership stake in Evolent Health Inc.'s Class A Common Stock as of September 30, 2025.

Eventide Asset Management, along with Finny Kuruvilla and Robin C. John, reported a 3.5% beneficial ownership stake in Evolent Health, Inc. Class A Common Stock.

Morgan Stanley and its subsidiary have disclosed a 7.0% beneficial ownership stake in Evolent Health, Inc.'s Class A Common Stock, held for passive investment purposes.

FMR LLC and Abigail P. Johnson have reported a beneficial ownership of 5.6% of Evolent Health Inc.'s Class A Common Stock as of June 30, 2025.

Durable Capital Partners LP has reported a significant beneficial ownership stake of 7.8% in Evolent Health, Inc., holding over 9.1 million shares of Class A Common Stock.

Wellington Management Group LLP and its affiliates have disclosed a 0.4% beneficial ownership stake in Evolent Health, Inc., holding 442,802 shares of common stock as of June 30, 2025.

Cadian Capital Management, LP, along with its affiliates and managing member Eric Bannasch, has disclosed a passive beneficial ownership of 9.3% in Evolent Health, Inc.'s Class A Common Stock as of March 31, 2025.

Eventide Asset Management, LLC, along with Finny Kuruvilla and Robin C. John, has filed a Schedule 13G disclosing beneficial ownership of 5.2% of Evolent Health, Inc.'s Class A Common Stock as of March 31, 2025.

RA Capital Management, along with Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P., have filed an amended Schedule 13G disclosing a 3.1% beneficial ownership stake in Evolent Health, Inc. as of December 31, 2024.

Wellington Management Group LLP and its affiliated entities have reported a beneficial ownership of 8.95% in Evolent Health, Inc., holding 10,436,495 shares of common stock as of December 31, 2024.